Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smith & Nephew Halts Sales Of Renasys Negative Pressure Wound Therapy

This article was originally published in The Gray Sheet

Executive Summary

FDA instructed to the company to obtain new clearances for design modifications already made to Renasys. The company says 510(k)s for these changes are pending.

You may also be interested in...



Orthopedics Earnings Roundup

Financial earnings reports from Smith & Nephew, Wright Medical, Zimmer, Stryker and Orthofix.

Acquisitions, New Technologies Reshaping Advanced Wound Care

Acquisitions and innovation are rapidly changing the dynamics in the global advanced wound care market, a high need, high growth market estimated at $5.4 billion in 2013. With the number of chronic wounds in major countries estimated at a whopping 26.7 million, the global advanced wound care market is projected to grow at a brisk 6% CAGR, reaching $7.3 billion by 2018.

Smith & Nephew Warning Letter Details Uncleared Product Modifications

A warning letter posted by FDA July 8 provides more details behind Smith & Nephew’s recent announcement that it was temporarily halting sales of its Renasys line of negative pressure wound therapy devices.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT033115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel